Oncternal Therapeutics, Inc. announced key additions to its board of directors with the appointments of William R. LaRue and Charles Theuer. Mr. LaRue has served in leadership roles including chief financial officer (CFO) with numerous publicly-traded biopharmaceutical companies, and brings significant financial expertise to Oncternal's board and audit committee. Most recently he served as CFO, senior vice president and treasurer at Cadence Pharmaceuticals, Inc. Dr. Theuer is currently president and chief executive officer of TRACON Pharmaceuticals where he is also a member of the board of directors.